Abstract
Achromobacter xylosoxidans is a rare cause of bacteremia, and little information on treatment is available. The majority of patients who have developed Achromobacter bacteremia have presented predisposing causes to the infection. A case of community-acquired pneumonia and bacteremia due to A. xylosoxidans in a previously healthy patient is reported. Achromobacter is usually resistant to ampicillin, cephalosporins (1st, 2nd, and 3rd generation), aminoglycosides, and fluoroquinolones. Piperacillin, piperacillin-tazobactam, and trimethoprim-sulfamethoxazole inhibit most isolates.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Aged, 80 and over
-
Alcaligenes / drug effects
-
Alcaligenes / isolation & purification*
-
Bacteremia / diagnosis
-
Bacteremia / microbiology*
-
Community-Acquired Infections / diagnosis
-
Community-Acquired Infections / drug therapy
-
Community-Acquired Infections / microbiology
-
Gram-Negative Bacterial Infections / diagnosis
-
Gram-Negative Bacterial Infections / drug therapy
-
Gram-Negative Bacterial Infections / microbiology*
-
Humans
-
Male
-
Pneumonia, Bacterial / diagnosis
-
Pneumonia, Bacterial / drug therapy
-
Pneumonia, Bacterial / microbiology*